#biosense

[symbiosisonlinepublishing]

𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: Biosensors can be used to detect and measure levels of specific molecules in blood, urine, and other bodily fluids. This information can be used to diagnose diseases, monitor the progression of diseases, and track the effectiveness of treatment. 𝐄𝐧𝐯𝐢𝐫𝐨𝐧𝐦𝐞𝐧𝐭𝐚𝐥 𝐦𝐨𝐧𝐢𝐭𝐨𝐫𝐢𝐧𝐠: Biosensors can be used to detect and measure pollutants in air, water, and soil. This information can be used to track the levels of pollutants in the environment, and to identify sources of pollution.

Visit: https://symbiosisonlinepublishing.com/biosensors-biomarkers-diagnostics/

[darshanan-blog]

Year ahead from BiotechShowcase & #Wuxi during JPM 2024

During the annual #JPM2024 healthcare conference week, by some accounts, 10,000 health technology professionals descended upon the city of San Francisco. Besides the flagship J. P. Morgan conference and #BiotechShowcase conference, there were numerous other conferences and events during the day and fancy and festive receptions during evening to late night hours. Broadly speaking, JP Morgan…

[reasonsforhope]

"A team of researchers at Washington University in St. Louis has developed a real-time air monitor that can detect any of the SARS-CoV-2 virus variants that are present in a room in about 5 minutes.

The proof-of-concept device was created by researchers from the McKelvey School of Engineering and the School of Medicine at Washington University...

The results are contained in a July 10 publication in Nature Communications that provides details about how the technology works.

The device holds promise as a breakthrough that - when commercially available - could be used in hospitals and health care facilities, schools, congregate living quarters, and other public places to help detect not only the SARS-CoV-2 virus, but other respiratory virus aerosol such as influenza and respiratory syncytial virus (RSV) as well.

“There is nothing at the moment that tells us how safe a room is,” Cirrito said, in the university’s news release. “If you are in a room with 100 people, you don’t want to find out five days later whether you could be sick or not. The idea with this device is that you can know essentially in real time, or every 5 minutes, if there is a live virus in the air.”

How It Works

The team combined expertise in biosensing with knowhow in designing instruments that measure the toxicity of air. The resulting device is an air sampler that operates based on what’s called “wet cyclone technology.” Air is sucked into the sampler at very high speeds and is then mixed centrifugally with a fluid containing a nanobody that recognizes the spike protein from the SARS-CoV-2 virus. That fluid, which lines the walls of the sampler, creates a surface vortex that traps the virus aerosols. The wet cyclone sampler has a pump that collects the fluid and sends it to the biosensor for detection of the virus using electrochemistry.

The success of the instrument is linked to the extremely high velocity it generates - the monitor has a flow rate of about 1,000 liters per minute - allowing it to sample a much larger volume of air over a 5-minute collection period than what is possible with currently available commercial samplers. It’s also compact - about one foot wide and 10 inches tall - and lights up when a virus is detected, alerting users to increase airflow or circulation in the room.

Testing the Monitor

To test the monitor, the team placed it in the apartments of two Covid-positive patients. The real-time air samples from the bedrooms were then compared with air samples collected from a virus-free control room. The device detected the RNA of the virus in the air samples from the bedrooms but did not detect any in the control air samples.

In laboratory experiments that aerosolized SARS-CoV-2 into a room-sized chamber, the wet cyclone and biosensor were able to detect varying levels of airborne virus concentrations after only a few minutes of sampling, according to the study.

“We are starting with SARS-CoV-2, but there are plans to also measure influenza, RSV, rhinovirus and other top pathogens that routinely infect people,” Cirrito said. “In a hospital setting, the monitor could be used to measure for staph or strep, which cause all kinds of complications for patients. This could really have a major impact on people’s health.”

The Washington University team is now working to commercialize the air quality monitor."

-via Forbes, July 11, 2023

-

Holy shit. I know it's still early in the technology and more testing will inevitably be needed but holy shit.

Literally, if it bears out, this could revolutionize medicine. And maybe let immunocompromised people fucking go places again

Also, for those who don't know, Nature Communications is a very prestigious scientific journal that focuses on Pretty Big Deal research. Their review process is incredibly rigorous. This is an absolutely HUGE credibility boost to this research and prototype

[mindblowingscience]

Researchers who want to bridge the divide between biology and technology spend a lot of time thinking about translating between the two different "languages" of those realms. "Our digital technology operates through a series of electronic on-off switches that control the flow of current and voltage," said Rajiv Giridharagopal, a research scientist at the University of Washington. "But our bodies operate on chemistry. In our brains, neurons propagate signals electrochemically, by moving ions—charged atoms or molecules—not electrons." Implantable devices from pacemakers to glucose monitors rely on components that can speak both languages and bridge that gap. Among those components are OECTs—or organic electrochemical transistors—which allow current to flow in devices like implantable biosensors. But scientists long knew about a quirk of OECTs that no one could explain: When an OECT is switched on, there is a lag before current reaches the desired operational level. When switched off, there is no lag. Current drops almost immediately. A UW-led study has solved this lagging mystery, and in the process paved the way to custom-tailored OECTs for a growing list of applications in biosensing, brain-inspired computation and beyond.

Continue Reading.

[darkmaga-retard]

https://stateofthenation.co/?p=244248

BEWARE! Highly toxic graphene is now being put into these very common injections

Posted on August 7, 2024 by State of the Nation

Torsion Spectroscopy Analysis Of Dental Anesthetics And Vitamin B12 Injections By Diana Wojtkowiak PhD – 10 Out Of 13 Batches Contain Graphene

Ana Maria Mihalcea, MD, PhD

Image courtesy: Graphene Oxide TEM Substrates https://aisthesis-products.com/graphene-oxide

Many people ask about nanotechnology in dental anesthetics. I hear of some people who ask their dentist and are told there is no mRNA in the anesthetics. Yes, that is correct, but that is not what we are concerned about. We are concerned about self assembly nanotechnology that can create a human machine interface. Its components are hydrogels made from many different chemical compositions, quantum dots, micro robotics for biosensing applications, toxic heavy metals, graphene, polymer plastics and more. Remember many teams did not find mRNA in the C19 shots. But we did find self assembly nanotechnology.

I have posted Dr. Diana Wojtkowiak PhD results on my substack previously She is the world renown developer of Torsion Spectroscopy, which allows for the chemical assessment of compounds in a novel way. Her research has made international news before:

The Expose: Polish Government Notified of Their Crime of Attempting to Legalize Genocide: 7 of 8 Medical Products Contained Graphene

Dr. Wojtkowiak did Torsion Analysis on the rubbery clots we had also analyzed:

Torsion Spectroscopy Of C19 Vaccinated Deceased Clots By Dr. Diana Wojtkowiak – Confirms Prion Like Protein That Cannot Be Dissolved With Conventional Blood Thinners

She also showed this groundbreaking research that the antimatter self of Covid 19 injected individuals is being altered:

Torsion Spectroscopy Evaluation Of Post C19 Injection Induced Magnetism And The Possible Implications For Humanity. Do The Bioweapons Modify Consciousness And Is Big Pharma Involved In The Paranormal?

Today she sent me an email with her most recent research. She analyzed multiple dental anesthetics in Poland as well as Vitamin B12 Injection. 10 out of 13 Batches contained graphene. Here are her results:

The results of the examination of dental anesthetics of two producers are presented below. Out of thirteen batch numbers (each batch is a preparation made of specific raw materials added to one filling of the boiler-mixer), three of them did not contain graphene:

Ubistesin forte 9231801 07/2024 3M ESPE,

Citocartin 100 U5K91 06/2024 Molteni Dental,

Mepidont 3% U52U1 06/2025 Molteni Dental.

In the others, there was graphene in variable amounts. Vitamin B12 also contained graphene. In the first table, the measurement of standard graphene, in the next three anesthetics from three sources (dental clinics), in the fourth vitamin B12. In the tables, the term “radiation from the sample”, gives a preliminary orientation that there is graphene, but it is not a sufficient measurement, it is necessary to make a fragment of the spectrum.

There are the graphs of the radiation spectrum below the tables, the designation e- is the signal of electrons from aromatic systems, not only for graphene, anesthetics are also aromatic. The blue designation e is the signals from the electron orbitals of graphene forming a complex aromatic system. There are about twenty of them on the whole spectrum, here I used only three. There are no such signals in the three charts, so these preparations are clean.

On the x-axis there are angles of setting of the spectroscope, corresponding to elementary particles, elements and aromatic systems, on the y-axis there are the range of radiation from the samples at the output of the spectroscope.

[materialsscienceandengineering]

3D printed electronic skin provides promise for human-machine interaction

With more than 1,000 nerve endings, human skin is the brain's largest sensory connection to the outside world, providing a wealth of feedback through touch, temperature and pressure. While these complex features make skin a vital organ, they also make it a challenge to replicate. By utilizing nanoengineered hydrogels that exhibit tunable electronic and thermal biosensing capabilities, researchers at Texas A&M University have developed a 3D-printed electronic skin (E-skin) that can flex, stretch and sense like human skin. "The ability to replicate the sense of touch and integrate it into various technologies opens up new possibilities for human-machine interaction and advanced sensory experiences," said Dr. Akhilesh Gaharwar, professor and director of research for the Department of Biomedical Engineering. "It can potentially revolutionize industries and improve the quality of life for individuals with disabilities."

Read more.

[soon-palestine]

Israeli air strike in Gaza kills prominent scientist Sufyan Tayeh, Palestinian ministry says

Reuters

Dec 2 An Israeli air strike targeting the neighborhood of Al-Faluja, 30 km (18 miles) northeast of Gaza City, has killed prominent Palestinian scientist Sufyan Tayeh and his family, the Palestinian Higher Education ministry announced on Saturday. Tayeh, who was president of the Islamic University of Gaza, was a leading researcher in physics and applied mathematics.

In 2005, he was arrested by Israeli occupation forces at the Rafah border crossing while he was heading to Egypt to complete the procedures for submitting his PhD dissertation at Ain Shams University. Over the period from 2008 to 2011, he assumed the position of Head of Physics Department at the Islamic University and he was appointed President of the University in August 2023.

Academic activity One of Dr. Tayeh’s research works was a proposal for scientific research in the field of optical sensors submitted to the University of Montreal, Canada. With the participation of Professor Ahmed Hamdan, Dr. Tayeh presented a research study entitled “Sensitivity enhancement in optical waveguide sensors”. The research paper aimed to explore multi-layer waveguide structures (more than 3 layers) for the purpose of optical biosensing, and to study the effect of anisotropic materials on the sensitivity of plate waveguide structures, in addition to studying more photonic crystals (two- and three-layer) with different compositions as well as the number of biosensing various layers.

Awards and honors Dr. Tayeh was winner of the Palestine Islamic Bank Award for Scientific Research for years 2019 and 2020. In March 2023, he was appointed holder of the UNESCO Chair for Physical, Astrophysical and Space Sciences in Palestine. He was recipient of the Abdul Hameed Shoman Award for Young Arab Scientists; and the winner of the Islamic University Award for Scientific Research for the year 2021. He was also ranked among the top 2% of researchers around the world in 2021. source

More than 1300 scientists from 40 countries, including physicists, mathematicians, biologists, chemists, medical doctors, engineers, and social scientists, working in academia and in industry, are compelled by the events in Gaza to call for an immediate permanent ceasefire and take a stand against war and the destructive use of science in an “International Convention Against War and Destructive Use of Science: Scientists Against Israeli Apartheid and Genocide in Gaza” on 9th December 2023. Prof. Richard A Falk, Emeritus Professor of International Law at Princeton University and Former UN Special Rapporteur for Palestine, was the keynote speaker in the Convention. He spoke ‘On the situation in Gaza.’ The Convention was moderated by Dr. Manabendra Nath Bera, a quantum information scientist from India. Dr. Flavio del Santo, a scientist from Switzerland, Dr. Niatalya Dinat, a medical doctor from South Africa, Prof. Josh Dubnau, from Sony Brook University, USA, and Prof. Assaf Kfoury, Boston University, USA, discussed possible amendments proposed by participants on the draft of the Declaration by the scientists. In the end, the amended Declaration was adopted after voting, with an absolute majority (97%).

The adopted Declaration embodies scientists’ protest against the destructive use and militarisation of science, Israeli occupation, apartheid, and genocide in Gaza, and call for an academic and scientific boycott and to stand by the Palestinian professors, scientists, researchers, scholars, and students.

[bpod-bpod]

Against the Grain

The intelligent part of artificial intelligence (AI) is mimicking our thought processes – making decisions based on logic and knowledge, and perhaps learning new rules along the way to hone these choices. But as deep-learning models grow more complex, the logic driving them can be lost in the code. Pictured under a scanning electron microscope, spotting different varieties of pollen grains, is a fresh challenge for artificial intelligence. A team of computer scientists and bioengineers sort grains by their different chemical and shape (morphological) properties using a form of explainable AI (xAI) – in which the artificial ‘thought processes’ are transparent and easy to follow. Apart making an excellent testing ground for xAI methods, the team are able to compare different models for classifying pollen, which may ultimately improve how we estimate pollen counts, make forecasts and promote advice to millions of people suffering allergies worldwide.

Written by John Ankers

Image from work by Sanja Brdar and colleagues

BioSense Institute - Research Institute for Information Technologies in Biosystems, University of Novi Sad, Novi Sad, Serbia

Image originally published with a Creative Commons Attribution 4.0 International (CC BY 4.0)

Published in Scientific Reports, February 2023

You can also follow BPoD on Instagram, Twitter and Facebook

[isfeed]

Wear OS watches might soon have an edge when it comes to blood oxygen

Masimo is keen to offer its expertise to Wear OS smartwatch makers for biosensing tech. | Photo by Amelia Holowaty Krales / The Verge Last week, medical device maker Masimo announced new deals with Google and Qualcomm to bring its biosensing tech to Wear OS smartwatches. That’s pretty inside baseball for the wearable industry, but it takes an interesting turn when you realize Masimo is also the…

[healthcare-skyquest]

Electrophysiology Market: Transforming Cardiac Care with Advanced Diagnostics

The Electrophysiology market is witnessing significant growth as cardiovascular diseases (CVDs) continue to be a leading cause of mortality worldwide. With advancements in diagnostic technology, electrophysiology is revolutionizing cardiac care by enabling precise diagnosis and treatment of heart rhythm disorders. This article explores the key market trends, segmentation, growth drivers, and leading companies shaping the electrophysiology industry.

Market Overview

According to SkyQuest’s Electrophysiology Market report, the market is currently valued at USD 8.20 billion in 2023, with a projected CAGR of 13%. The increasing prevalence of heart diseases, growing adoption of minimally invasive procedures, and advancements in electrophysiology devices are propelling the market forward.

Request Your Free Sample: - https://www.skyquestt.com/sample-request/electrophysiology-market

Market Segmentation

By Product Type:

Electrophysiology Ablation Catheters: Key devices for treating arrhythmias through minimally invasive procedures.

Electrophysiology Diagnostic Catheters: Widely used in diagnosing electrical activity in the heart.

Electrophysiology Lab Devices: Includes mapping systems and recording devices for advanced diagnostics.

Pacemakers and Defibrillators: Crucial for regulating heart rhythms in patients with severe arrhythmias.

Others: Includes specialized tools and equipment for electrophysiological procedures.

By Indication:

Atrial Fibrillation: One of the most common cardiac arrhythmias, where electrophysiology plays a significant role in treatment.

Atrioventricular Nodal Reentrant Tachycardia (AVNRT): A fast heart rhythm disorder often treated with ablation.

Wolff-Parkinson-White Syndrome (WPW): A rare condition where electrophysiology diagnostics are essential for management.

Other Arrhythmias: Includes ventricular tachycardia and flutter, both addressed through electrophysiology treatments.

By End-User:

Hospitals: Major centers for electrophysiology procedures and treatments.

Ambulatory Surgical Centers: Increasingly adopting electrophysiology for outpatient treatments.

Cardiac Centers: Specialized in diagnosing and treating heart rhythm disorders.

Others: Includes research institutions and academic centers focused on cardiac care.

Key Growth Drivers

Rising Incidence of Cardiovascular Diseases: The global rise in heart diseases is fueling demand for advanced electrophysiology diagnostics and treatments.

Technological Advancements: Innovations in catheter ablation, 3D mapping systems, and minimally invasive procedures are enhancing the market's growth potential.

Growing Preference for Minimally Invasive Surgeries: Electrophysiology procedures are less invasive, leading to faster recovery times, which is driving their adoption.

Increased Healthcare Spending: Governments and healthcare providers are investing heavily in cardiac care, boosting the demand for electrophysiology solutions.

Read More at: - https://www.skyquestt.com/report/electrophysiology-market

Leading Companies in the Market

SkyQuest’s report highlights key players dominating the Electrophysiology Market, including:

Johnson & Johnson

Abbott Laboratories

Medtronic PLC

Boston Scientific Corporation

Siemens Healthineers AG

MicroPort Scientific Corporation

Biotronik SE & Co. KG

GE Healthcare

Koninklijke Philips N.V.

Biosense Webster, Inc.

Take Action Now: Secure Your Report Today - https://www.skyquestt.com/buy-now/electrophysiology-market

Challenges and Opportunities

High costs associated with electrophysiology procedures and devices pose a challenge, especially in developing regions. However, the ongoing research and development efforts to create cost-effective and advanced devices offer vast opportunities for market growth. The increasing availability of mobile healthcare services and remote diagnostics also opens new avenues for expansion.

Future Outlook

The Electrophysiology Market is poised for continued growth, driven by technological advancements and the increasing burden of cardiovascular diseases globally. Companies that focus on developing innovative and cost-effective solutions are well-positioned to capitalize on the growing demand for electrophysiology procedures.

As the need for effective cardiac care intensifies, the electrophysiology market is at the forefront of diagnostic and treatment innovations. Healthcare providers and decision-makers must stay updated with the latest trends and technologies to ensure optimal patient outcomes. For a detailed analysis and strategic insights, consult SkyQuest's comprehensive Electrophysiology Market report.

[health-views-updates]

Heart Failure POC & LOC Devices Market Trends: Future Growth and Opportunities

The global market for heart failure Point-of-Care (POC) and Lab-on-Chip (LOC) devices is expected to witness explosive growth over the coming decade. Valued at USD 95.94 million in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 17.26%, reaching USD 401.91 million by 2032. This dramatic rise highlights the increasing reliance on advanced diagnostic technologies to improve outcomes for heart failure patients.

POC and LOC devices represent a significant leap forward in medical diagnostics, offering real-time, rapid diagnostic results at the patient's location rather than in centralized laboratories. These devices are critical for diagnosing and managing heart failure, as they allow for immediate detection of biomarkers and real-time monitoring of patient health, enabling timely and effective treatment.

Key Drivers of Market Growth

Increasing Prevalence of Heart Failure: Heart failure has become a global health concern, with millions affected worldwide. The rising incidence of heart failure, particularly in aging populations and regions with high cardiovascular disease rates, is a major factor driving the demand for POC and LOC diagnostic devices. As the global burden of heart failure continues to grow, the need for faster, more accurate diagnostic tools becomes critical for timely intervention and improved patient outcomes.

Technological Advancements in Diagnostics: Innovations in miniaturization, biosensing technologies, and microfluidics have led to the development of highly efficient POC and LOC devices. These advancements are enabling more accurate detection of biomarkers such as natriuretic peptides and troponins, which are essential for diagnosing heart failure. As the technology behind these devices continues to evolve, their reliability and ease of use are expected to further enhance their adoption in both clinical and home settings.

Rising Demand for Rapid and Remote Diagnostics: With the increasing emphasis on early detection and personalized healthcare, there is a growing demand for diagnostic devices that can provide rapid results in non-hospital settings. POC devices are particularly valuable in emergency departments, primary care clinics, and even home care, where they enable healthcare providers and patients to make faster decisions regarding treatment. The ability to monitor heart failure progression outside traditional hospital settings is transforming how chronic diseases are managed.

Growing Focus on Personalized Medicine: Personalized medicine has emerged as a key trend in healthcare, particularly in the management of chronic diseases like heart failure. POC and LOC devices allow for real-time monitoring of specific patient biomarkers, making it possible to tailor treatment plans to individual needs. This shift toward personalized care, combined with the desire to reduce healthcare costs, is expected to fuel demand for these devices in the coming years.

Get a Free Sample Report : https://www.snsinsider.com/sample-request/2565 

Challenges and Opportunities

While the market for heart failure POC and LOC devices presents vast growth opportunities, certain challenges remain. One of the primary challenges is the cost of advanced diagnostic devices, which may limit accessibility in lower-income regions or underfunded healthcare systems. Additionally, the integration of these devices into existing healthcare workflows and reimbursement policies can be complex and may require more widespread regulatory support.

However, these challenges are being met with ongoing innovations in device affordability and regulatory reforms, aimed at improving access to advanced diagnostic tools across diverse healthcare markets. Collaboration between device manufacturers, healthcare providers, and regulatory bodies is expected to ease these barriers and accelerate the widespread adoption of POC and LOC technologies.

Regional Insights

North America holds the largest share of the heart failure POC and LOC devices market, driven by the region’s advanced healthcare infrastructure, high prevalence of cardiovascular diseases, and increasing investments in healthcare technology. Europe follows closely, with strong demand for personalized diagnostics and growing support for healthcare innovations.

The Asia-Pacific region is expected to experience the fastest growth during the forecast period, driven by the rising incidence of cardiovascular diseases, increasing healthcare expenditures, and the growing adoption of advanced diagnostic technologies in countries such as China, Japan, and India.

Future Outlook

The heart failure POC and LOC devices market is on track for substantial growth as technological innovations, patient-centric healthcare, and the rising demand for real-time diagnostics converge. With a projected CAGR of 17.26% from 2024 to 2032, the market is set to reach USD 401.91 million by 2032, offering significant opportunities for device manufacturers, healthcare providers, and patients alike.

In conclusion, the demand for heart failure POC and LOC devices is poised to rise sharply in the coming years, driven by advancements in diagnostic technology, the increasing prevalence of heart failure, and the growing need for personalized and remote healthcare solutions. This burgeoning market is set to redefine the future of heart failure management and improve patient outcomes globally

[jobrxiv]

PhD Position in Bioengineering and Biosensing CIC biomagune See the full job description on jobRxiv: https://jobrxiv.org/job/cic-biomagune-27778-phd-position-in-bioengineering-and-biosensing/?feed_id=81406 #3D_cell_culture #biomarkers #biomaterials #nanomicroparticles #Plasmonics #ScienceJobs #hiring #research

[colinwilson11]

The Rising Pulse Field Ablation Market Driven By Increasing Adoption For Complex Cardiac Ablations

Pulsed field ablation is a minimally invasive procedure that is used to treat cardiac arrhythmias through applying electromagnetic pulses for ablating heart tissues. It delivers high electric fields which selectively target and ablate cardiac tissues without damaging surrounding structures.This reduces risk of complications like blood clots, and charring as compared to radiofrequency ablation.The procedure is generally preferred for complex ablations involving ablation of critical structures like the pulmonary veins, mitral isthmus and cavotricuspid isthmus line. The rising prevalence of cardiovascular diseases and increasing focus on early treatment and management of complex cardiac arrhythmias is driving the demand for pulsed field ablation globally.

The Pulsed Field Ablation Market is estimated to be valued at US$ 3.52 Bn in 2024 and is expected to exhibit a CAGR of 7.8%��over the forecast period of 2024 to 2031.

Key Takeaways

Key players operating in the pulsed field ablation market are Medtronic, Boston Scientific, Johnson & Johnson (Biosense Webster), Abbott Laboratories, Kardium. Key players are focusing on developing advanced pulsed field ablation catheters and systems with improved navigation, precision and safety. The growing adoption of minimally invasive cardiac ablation procedures for treating arrhythmias is a major factor boosting demand. Technological advancements including incorporation of 3D catheter tracking and visualization is allowing pulsed field ablation to be utilized for more complex ablations with improved outcomes.

Market Trends

One of the key trends witnessed in the pulsed field ablation market is the development of pulsed field ablation catheters and system with irrigated tip technology. Irrigated tip ablation helps in overcoming challenges of steam pops and charring by maintaining tip-tissue interface. This improves safety and efficacy of ablation. Another trend is the increasing integration of pulsed field ablation with robotic navigation systems. Robotic pulsed field ablation allows electrophysiologists to perform complex ablations more precisely with improved ergonomics. This is expected to drive adoption.

Market Opportunities

Rising focus on emerging economies in Asia Pacific and Latin America presents significant growth opportunities due to increasing healthcare expenditure and focus on early treatment of cardiovascular diseases in these regions. Growing popularity of minimally invasive cardiac procedures also provides scope for pulsed field ablation adoption. Development of pulsed field ablation solutions suitable for pediatric cardiac ablations further aids in expanding indications.

Impact Of COVID-19 On Pulsed Field Ablation Market Growth

The COVID-19 pandemic has significantly impacted the growth of the pulsed field ablation market. During the initial lockdown phases in 2020, elective medical procedures like pulsed field ablation were postponed to avoid unnecessary exposure and prioritize urgent treatments. This led to a decline in the demand for pulsed field ablation products as their usage was limited only for emergency cases.

As restrictions eased in mid-2020, market players started instilling heightened safety measures like sanitization, social distancing and use of personal protective equipment during pulsed field ablation procedures to prevent infection spread. However, hospitals continued to maintain selective treatment approach and capacity limits due to resource constraints and priority cases. This hampered the market recovery during the remainder of 2020 and through 2021.

Gradually as vaccination drives were rolled out on a mass scale from late-2021 to 2022, confidence levels of patients as well as healthcare facilities improved. More resources were diverted for non-COVID care and pulsed field ablation procedures regained lost momentum. Market players focused on expanding operational capabilities and setup virtual or hybrid care models to bridge care gaps. Various government bodies and private organizations also ramped up investments to cater to postponed medical needs and overcome backlogs. These measures helped strengthen the adoption of pulsed field ablation in the post-COVID period. Going forward, market players need to invest in healthcare infrastructure development, supply chain resilience, workforce training programs and innovations to sustain gains achieved in the recovery phase. Telehealth can play a bigger role to provide affordable and accessible care. Sustained vaccination efforts and streamlined infection control protocols will further aid unhindered growth in the future.

North America Pulsed Field Ablation Market Growth

In terms of value, North America contributed the largest share to the Pulsed Field Ablation Market in 2022. Presence of advanced healthcare infrastructure and universal health coverage aided early market penetration across the US and Canada. Favorable reimbursement policies increased affordability of pulsed field ablation procedures.

Rising prevalence of atrial fibrillation, an arrhythmia commonly treated with pulsed field ablation, drove the regional market. According to estimates, over 6 million Americans were likely to be diagnosed with atrial fibrillation by 2030. This high disease burden attracted public and private investments towards innovative ablation treatments. In addition, presence of leading ablation device manufacturers in the US benefited regional market access. Patented product portfolios ensured price premiums and steady revenue stream. Moreover, developed economies with higher patient affordability and awareness levels enabled North America to maintain its dominance in the global landscape.

Fastest Growing Asia Pacific Pulsed Field Ablation Market Region

The Asia Pacific region is poised to witness the fastest growth in the pulsed field ablation market during the forecast period. This can be attributed to rising healthcare expenditures, rapid economic development and growing focus towards non-communicable disease management across developing countries. China, India and South Korea in particular are expected to fuel the regional market expansion due to their huge population bases and unmet medical needs. Escalating incidence rates of diabetes and hypertension, both leading risk factors for atrial fibrillation, have significantly escalated the patient pool requiring ablation treatment. Favorable government initiatives aimed at boosting healthcare access through universal coverage and infrastructure investments are also aiding the market growth. Various multinational medtech companies have directed their focus towards developing cost-effective ablation solutions tailored for this region. Emergence of regional generics manufacturing hubs has improved local availability while lowering overall treatment costs. All these factors are contributing to Asia Pacific emerging as the most lucrative market for pulsed field ablation globally.

Get more insights on this topic: https://www.trendingwebwire.com/pulsed-field-ablation-market-is-estimated-to-witness-high-growth-owing-to-technological-advancements-in-cardiac-ablation-procedures/

About Author:

Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn - https://www.linkedin.com/in/priya-pandey-8417a8173/)

What Are The Key Data Covered In This Pulsed Field Ablation Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Pulsed Field Ablation Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Pulsed Field Ablation Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Pulsed Field Ablation Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Pulsed Field Ablation Market vendors

FAQ’s

Q.1 What are the main factors influencing the Pulsed Field Ablation Market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top Pulsed Field Ablation Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the Pulsed Field Ablation Market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

*Note: 1. Source: Coherent Market Insights, Public sources, Desk research 2. We have leveraged AI tools to mine information and compile it

[biotech-news-feed]

Biosense Webster, a part of Johnson & Johnson MedTech, has completed enrolment for the Omny-IRE clinical trial to assess Omnypulse Platform in atrial fibrillation (AFib) treatment. The post Biosense Webster completes enrolment for Omnypulse Platform #BioTech #science

[nuadox]

Researchers develop low-cost saliva test for heart failure screening at home

- By Nuadox Crew -

A team of researchers has developed a low-cost, point-of-care electrochemical biosensor that can screen for heart failure at home.

Video: "Saliva test gives heart failure prognosis on demand" by ACS, YouTube.

This prototype, resembling a transparent lateral flow test, detects two biomarkers from just a drop of saliva in about 15 minutes. Trey Pittman, a graduate student at Colorado State University, will present the research at the American Chemical Society's Fall 2024 meeting. The device targets people in rural or low-resource areas with limited access to healthcare. Current heart failure screening typically involves blood tests conducted twice a year, but this new tool could enable frequent, at-home saliva tests.

The biosensor, known as an electrochemical capillary-driven immunoassay (eCaDI), combines microfluidic and biosensing technologies. It is composed of five layers, including plastic, adhesive, blotting paper, and electrodes, and costs around $3 to produce. Initial tests showed that the eCaDI could accurately detect the heart failure biomarkers Galectin-3 and S100A7. The next phase involves human trials at Griffith University in Australia.

This technology could also be adapted for other diseases, offering an accessible solution for underserved populations. The research was supported by the U.S. National Institutes of Health.

Read more at American Chemical Society (ACS)

Real Also

Molecule tested at University of São Paulo proves able to mitigate heart failure

[materialsscienceandengineering]

Researchers develop technique to synthesize water-soluble alloy nanoclusters

In recent years, ultrasmall metal nanoclusters have unlocked advances in fields ranging from bioimaging and biosensing to biotherapy, thanks to their unique molecular-like properties. In a study published in the journal Polyoxometalates, a research team from Qingdao University of Science and Technology proposed a design to synthesize atomically precise, water-soluble alloy nanoclusters. "The novelty of this study is in a new strategy for the synthesis of water-soluble alloy nanoclusters and a further contribution to the fundamental understanding of the alloying mechanism of metal nanoclusters," said study author Xun Yuan from Qingdao University of Science and Technology. "The ultimate goal is to develop such alloy nanoclusters as novel nanomedicine," Yuan said.

Read more.